Think of them as expert trainers for confused immune cells
8-12 hours IM) Preferred by 64% of patients who've tried both Intramuscular (into deltoid or vastus lateralis, using a 22-25 gauge, 1-inch needle): 41% report injection-site soreness Faster absorption More difficult self-administration for some sites (deltoid requires non-dominant arm injection) Preferred by 36% of patients who've tried both The efficacy difference is minimal
Bari I, Staufner C, Augoustides-Savvopoulou P, Chien YH, Dobbelaere D, Grnert SC, Opladen T, Petkovi Ramada D, Raki B, Wedell A, Blom HJ (2017a) Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders
This distinction is especially important when customers read broad statements such as FDA is allowing peptides or FDA is banning peptides. Neither statement accurately describes the scope of this meeting